Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial

Universitatsklinikum Benjamin Franklin, Berlin, Germany.

OBJECTIVES. This study was undertaken to assess prospectively the prognostic power of early ST segment elevation resolution in a large cohort of patients with myocardial infarction and to test the value of differences in ST segment resolution as a surrogate end point. BACKGROUND. Previous studies revealed that the use of two cutoff points for three groups of ST segment resolution within 3 h after the start of thrombolysis is most effective in predicting outcome. METHODS. The International Joint Efficacy Comparison of Thrombolytics (INJECT) trial compared mortality in 6,010 patients randomized to receive either reteplase or streptokinase. The 1,909 German patients form the basis of this substudy. The three groups of ST segment resolution were defined as complete (> or = 70%), partial (70% to 30%) and no resolution (< 30% to > or = 0%). RESULTS. In 1,398 patients presenting < or = 6 h from onset of acute myocardial infarction, the 35-day mortality rate for complete, partial and no ST segment resolution was 2.5%, 4.3% and 17.5%, respectively (p < 0.0001). Peak creatine kinase levels (fraction of normal) were 9.8, 13.4 and 14.0, respectively (p < 0.0001). When baseline characteristics were included, ST segment resolution was the most powerful independent predictor of 35-day mortality. The proportion of patients with complete ST segment resolution was larger, and that with no ST segment resolution smaller, with reteplase than with streptokinase (p = 0.006). CONCLUSIONS. No ST segment resolution, indicating failed thrombolysis, predicts very high early mortality, whereas complete resolution is associated with a small infarct area and low mortality. Partial ST segment resolution also predicts larger infarct areas, but early mortality is relatively low. Different extents of ST segment resolution may serve as a sensitive surrogate end point in clinical trials.

This article has been cited by other articles:

				M. Sejersten, N. Valeur, P. Grande, T. T. Nielsen, P. Clemmensen, and for the DANAMI-2 Investigators Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction-2). J. Am. Coll. Cardiol., November 3, 2009; 54(19): 1763 - 1769. [Abstract] [Full Text] [PDF]

				F. Liistro, S. Grotti, P. Angioli, G. Falsini, K. Ducci, S. Baldassarre, A. Sabini, R. Brandini, E. Capati, and L. Bolognese Impact of Thrombus Aspiration on Myocardial Tissue Reperfusion and Left Ventricular Functional Recovery and Remodeling After Primary Angioplasty Circ Cardiovasc Interv, October 1, 2009; 2(5): 376 - 383. [Abstract] [Full Text] [PDF]

				K R Bainey, Y Fu, C B Granger, C W Hamm, D R Holmes Jr, W W O'Neill, R Seabra-Gomes, M E Pfisterer, F Van de Werf, P W Armstrong, et al. Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients? Heart, August 15, 2009; 95(16): 1331 - 1336. [Abstract] [Full Text] [PDF]

				P. W. Armstrong, Y. Fu, C. M. Westerhout, M. P. Hudson, K. W. Mahaffey, H. D. White, T. G. Todaro, P. X. Adams, P. E.G. Aylward, and C. B. Granger Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. J. Am. Coll. Cardiol., April 28, 2009; 53(17): 1503 - 1509. [Abstract] [Full Text] [PDF]

				C-K Wong, W Gao, R A H Stewart, J K French, P E G Aylward, and H D White Relationship of QRS duration at baseline and changes over 60 min after fibrinolysis to 30-day mortality with different locations of ST elevation myocardial infarction: results from the Hirulog and Early Reperfusion or Occlusion-2 trial Heart, February 1, 2009; 95(4): 276 - 282. [Abstract] [Full Text] [PDF]

				J. P Piccini and E M. Ohman ECG interpretation in ST-elevation myocardial infarction: pattern recognition or caliper measurements? Heart, February 1, 2009; 95(4): 267 - 268. [Full Text] [PDF]

				C. E. Buller, Y. Fu, K. W. Mahaffey, T. G. Todaro, P. Adams, C. M. Westerhout, H. D. White, A. W.J. van 't Hof, F. J. Van de Werf, G. S. Wagner, et al. ST-Segment Recovery and Outcome After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Trial Circulation, September 23, 2008; 118(13): 1335 - 1346. [Abstract] [Full Text] [PDF]

				Y. Ikari, M. Sakurada, K. Kozuma, S. Kawano, T. Katsuki, K. Kimura, T. Suzuki, T. Yamashita, A. Takizawa, K. Misumi, et al. Upfront Thrombus Aspiration in Primary Coronary Intervention for Patients With ST-Segment Elevation Acute Myocardial Infarction: Report of the VAMPIRE (VAcuuM asPIration thrombus REmoval) Trial J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 424 - 431. [Abstract] [Full Text] [PDF]

				M. A. McDonald, Y. Fu, U. Zeymer, G. Wagner, S. G. Goodman, A. Ross, C. B. Granger, F. Van de Werf, P. W. Armstrong, and for the ASSENT-4 PCI Investigators Adverse outcomes in fibrinolytic-based facilitated percutaneous coronary intervention: insights from the ASSENT-4 PCI electrocardiographic substudy Eur. Heart J., April 1, 2008; 29(7): 871 - 879. [Abstract] [Full Text] [PDF]

				M Toma, Y Fu, G Wagner, S G Goodman, C Granger, L Wallentin, F Van de Werf, and P Armstrong Risk stratification in ST-elevation myocardial infarction is enhanced by combining baseline ST deviation and subsequent ST-segment resolution Heart, March 1, 2008; 94(3): e6 - e6. [Abstract] [Full Text] [PDF]

				L A Pierard ST elevation after myocardial infarction: what does it mean? Heart, November 1, 2007; 93(11): 1329 - 1330. [Abstract] [Full Text] [PDF]

				L. Galiuto, S. Barchetta, S. Paladini, G. Lanza, A. G Rebuzzi, M. Marzilli, and F. Crea Functional and structural correlates of persistent ST elevation after acute myocardial infarction successfully treated by percutaneous coronary intervention Heart, November 1, 2007; 93(11): 1376 - 1380. [Abstract] [Full Text] [PDF]

				M. Sezer, H. Oflaz, T. Goren, I. Okcular, B. Umman, Y. Nisanci, A. K. Bilge, Y. Sanli, M. Meric, and S. Umman Intracoronary Streptokinase after Primary Percutaneous Coronary Intervention N. Engl. J. Med., May 3, 2007; 356(18): 1823 - 1834. [Abstract] [Full Text] [PDF]

				A. Kaltoft, M. Bottcher, S. S. Nielsen, H.-H. T. Hansen, C. Terkelsen, M. Maeng, J. Kristensen, L. Thuesen, L. R. Krusell, S. D. Kristensen, et al. Routine Thrombectomy in Percutaneous Coronary Intervention for Acute ST-Segment-Elevation Myocardial Infarction: A Randomized, Controlled Trial Circulation, July 4, 2006; 114(1): 40 - 47. [Abstract] [Full Text] [PDF]

				P. W. Armstrong and WEST Steering Committee A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study Eur. Heart J., July 1, 2006; 27(13): 1530 - 1538. [Abstract] [Full Text] [PDF]

				E Bjorklund, T Jernberg, P Johanson, P Venge, M Dellborg, L Wallentin, B Lindahl, and the ASSENT-2 and ASSENT-PLUS Study Groups Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction Heart, June 1, 2006; 92(6): 735 - 740. [Abstract] [Full Text] [PDF]

				W.-C. Chang, P. Kaul, Y. Fu, C. M. Westerhout, C. B. Granger, K. W. Mahaffey, L. Wallentin, F. Van de Werf, P. W. Armstrong, and for the ASSENT-3 Investigators Forecasting mortality: dynamic assessment of risk in ST-segment elevation acute myocardial infarction Eur. Heart J., February 2, 2006; 27(4): 419 - 426. [Abstract] [Full Text] [PDF]

				A. H. Gershlick, A. Stephens-Lloyd, S. Hughes, K. R. Abrams, S. E. Stevens, N. G. Uren, A. de Belder, J. Davis, M. Pitt, A. Banning, et al. Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial Infarction N. Engl. J. Med., December 29, 2005; 353(26): 2758 - 2768. [Abstract] [Full Text] [PDF]

				A G C Sutton, P G Campbell, R Graham, D J A Price, J C Gray, E D Grech, J A Hall, A A Harcombe, R A Wright, R H Smith, et al. One year results of the Middlesbrough early revascularisation to limit infarction (MERLIN) trial Heart, October 1, 2005; 91(10): 1330 - 1337. [Abstract] [Full Text] [PDF]

				E. Ilkay, I. Karaca, M. Yavuzkir, M. Akbulut, and M. Pekdemir The Effect of Interventional Treatment in Acute Myocardial Infarction on ST Resolution: A Comparison of Coronary Angioplasty with Excimer Laser Angioplasty Angiology, July 1, 2005; 56(4): 377 - 384. [Abstract] [PDF]

				P. Sorajja, B. J. Gersh, C. Costantini, M. G. McLaughlin, P. Zimetbaum, D. A. Cox, E. Garcia, J. E. Tcheng, R. Mehran, A. J. Lansky, et al. Combined prognostic utility of ST-segment recovery and myocardial blush after primary percutaneous coronary intervention in acute myocardial infarction Eur. Heart J., April 1, 2005; 26(7): 667 - 674. [Abstract] [Full Text] [PDF]

				G. W. Stone, J. Webb, D. A. Cox, B. R. Brodie, M. Qureshi, A. Kalynych, M. Turco, H. P. Schultheiss, D. Dulas, B. D. Rutherford, et al. Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial JAMA, March 2, 2005; 293(9): 1063 - 1072. [Abstract] [Full Text] [PDF]

				M. W. Krucoff, P. Johanson, R. Baeza, S. W. Crater, and M. Dellborg Clinical Utility of Serial and Continuous ST-Segment Recovery Assessment in Patients With Acute ST-Elevation Myocardial Infarction: Assessing the Dynamics of Epicardial and Myocardial Reperfusion Circulation, December 21, 2004; 110(25): e533 - e539. [Full Text] [PDF]

				M. G. McLaughlin, G. W. Stone, E. Aymong, G. Gardner, R. Mehran, A. J. Lansky, C. L. Grines, J. E. Tcheng, D. A. Cox, T. Stuckey, et al. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: The controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1215 - 1223. [Abstract] [Full Text] [PDF]

				A. G. C. Sutton, P. G. Campbell, R. Graham, D. J. A. Price, J. C. Gray, E. D. Grech, J. A. Hall, A. A. Harcombe, R. A. Wright, R. H. Smith, et al. A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: The Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial J. Am. Coll. Cardiol., July 21, 2004; 44(2): 287 - 296. [Abstract] [Full Text] [PDF]

				T. Taher, Y. Fu, G. S. Wagner, S. G. Goodman, C. Fresco, C. B. Granger, L. Wallentin, F. Van de Werf, F. Verheugt, and P. W. Armstrong Aborted myocardial infarction in patients with ST-segment elevation: Insights from the assessment of the safety and efficacy of a new thrombolytic regimen-3 trial electrocardiographic substudy J. Am. Coll. Cardiol., July 7, 2004; 44(1): 38 - 43. [Abstract] [Full Text] [PDF]

				J. Cortadellas, J. Figueras, M. Missorici, E. Domingo, J. Rodes, J. Castell, and J. Soler Soler ST segment elevation at 72 hours in patients with a first anterior myocardial infarction best correlates with pre-discharge and 1-year regional contractility and ventricular dilatation Eur. Heart J., February 1, 2004; 25(3): 224 - 231. [Abstract] [Full Text] [PDF]

				M Sezer, Y Nisanci, B Umman, E Yilmaz, A Olcay, F Erzengin, and O Ozsaruhan New support for clarifying the relation between ST segment resolution and microvascular function: degree of ST segment resolution correlates with the pressure derived collateral flow index Heart, February 1, 2004; 90(2): 146 - 150. [Abstract] [Full Text] [PDF]

				E. Bjorklund, B. Lindahl, P. Johanson, T. Jernberg, A.-M. Svensson, P. Venge, L. Wallentin, M. Dellborg, and the ASSENT-2 and ASSENT-PLUS study groups Admission Troponin T and measurement of ST-segment resolution at 60 min improve early risk stratification in ST-elevation myocardial infarction Eur. Heart J., January 2, 2004; 25(2): 113 - 120. [Abstract] [Full Text] [PDF]

				P. W. Armstrong and R. C. Welsh Tailoring therapy to best suit ST-segment elevation myocardial infarction: searching for the right fit Can. Med. Assoc. J., October 28, 2003; 169(9): 925 - 927. [Full Text]

				P. W. Armstrong, G. Wagner, S. G. Goodman, F. Van de Werf, C. Granger, L. Wallentin, Y. Fu, and for the ASSENT 3 Investigators ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction Eur. Heart J., August 2, 2003; 24(16): 1515 - 1522. [Abstract] [Full Text] [PDF]

				L. J. Feldman, P. Coste, A. Furber, P. Dupouy, M. S. Slama, J.-P. Monassier, C. Tron, A. Lafont, M. Faraggi, D. Le Guludec, et al. Incomplete Resolution of ST-Segment Elevation Is a Marker of Transient Microcirculatory Dysfunction After Stenting for Acute Myocardial Infarction Circulation, June 3, 2003; 107(21): 2684 - 2689. [Abstract] [Full Text] [PDF]

				P. Johanson, T. Jernberg, G. Gunnarsson, B. Lindahl, L. Wallentin, and M. Dellborg Prognostic value of ST-segment resolution--when and what to measure Eur. Heart J., February 2, 2003; 24(4): 337 - 345. [Abstract] [Full Text] [PDF]

				N. J. Goswami, J. M. Moody Jr, and S. R. Bailey Percutaneous Mechanical Reperfusion During Acute Myocardial Infarction J Intensive Care Med, July 1, 2002; 17(4): 162 - 173. [Abstract] [PDF]

				E.M. Antman, H.A. Cooper, C.M. Gibson, J.A. de Lemos, C.H. McCabe, R.P. Giugliano, P. Coussement, S. Murphy, J. Scherer, K. Anderson, et al. Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction. Insights from TIMI 14 and InTIME-II Eur. Heart J., June 2, 2002; 23(12): 928 - 933. [Abstract] [Full Text] [PDF]

				G. W. Stone, M. A. Peterson, A. J. Lansky, G. Dangas, R. Mehran, and M. B. Leon Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction J. Am. Coll. Cardiol., February 20, 2002; 39(4): 591 - 597. [Abstract] [Full Text] [PDF]

				Y. Fu, S. Goodman, W.-C. Chang, F. Van de Werf, C. B. Granger, and P. W. Armstrong Time to Treatment Influences the Impact of ST-Segment Resolution on One-Year Prognosis: Insights From the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Trial Circulation, November 27, 2001; 104(22): 2653 - 2659. [Abstract] [Full Text] [PDF]

				F. Van de Werf New aspects of pharmacological reperfusion: from macro- to microlysis Eur. Heart J. Suppl., June 1, 2001; 3(suppl_C): C62 - C68. [Abstract] [PDF]

				R.G. Wilcox ST-segment elevation resolution -- a surrogate for infarct vessel patency or myocardial perfusion, but a call for rescue? Eur. Heart J., May 1, 2001; 22(9): 722 - 724. [PDF]

				A.M. Antman, J.A. de Lemos, and E. Braunwald Epicardial flow and myocardial reperfusion following abciximab and low-dose thrombolytic therapy for acute myocardial infarction Eur. Heart J. Suppl., May 1, 2001; 3(suppl_A): A8 - A13. [Abstract] [PDF]

				M. T. Roe, E. M. Ohman, A. C. P. Maas, R. H. Christenson, K. W. Mahaffey, C. B. Granger, R. A. Harrington, R. M. Califf, and M. W. Krucoff Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion J. Am. Coll. Cardiol., January 1, 2001; 37(1): 9 - 18. [Abstract] [Full Text] [PDF]

				E. M. Ohman, R. A. Harrington, C. P. Cannon, G. Agnelli, J. A. Cairns, and J.W. Kennedy Intravenous Thrombolysis in Acute Myocardial Infarction Chest, January 1, 2001; 119 (2009): 253S - 277S. [Full Text] [PDF]

				E.M Antman, C.M Gibson, J.A de Lemos, R.P Giugliano, C.H McCabe, P Coussement, I Menown, C.A Nienaber, T.C Rehders, M.J Frey, et al. Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14 Eur. Heart J., December 1, 2000; 21(23): 1944 - 1953. [Abstract] [PDF]

				R Schroder, U Zeymer, K Wegscheider, and K.L Neuhaus Comparison of the predictive value of ST segment elevation resolution at 90 and 180min after start of streptokinase in acute myocardial infarction. A substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 Study Eur. Heart J., November 1, 1999; 20(21): 1563 - 1571. [Abstract] [PDF]

				K.-L. Neuhaus, G. P. Molhoek, U. Zeymer, U. Tebbe, K. Wegscheider, R. Schroder, A. Camez, G. J. Laarman, G. M. Grollier, D. J. A. Lok, et al. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: Results of the HIT-4 trial J. Am. Coll. Cardiol., October 1, 1999; 34(4): 966 - 973. [Abstract] [Full Text] [PDF]

				M. J. Claeys, J. Bosmans, L. Veenstra, P. Jorens, Herbert De Raedt, and C. J. Vrints Determinants and Prognostic Implications of Persistent ST-Segment Elevation After Primary Angioplasty for Acute Myocardial Infarction : Importance of Microvascular Reperfusion Injury on Clinical Outcome Circulation, April 20, 1999; 99(15): 1972 - 1977. [Abstract] [Full Text] [PDF]

				R. L White Thrombolytic Therapy in Acute Myocardial Infarction Part II: 1997 Update Asian Cardiovasc Thorac Ann, March 1, 1998; 6(1): 03 - 10. [Abstract] [Full Text] [PDF]

				I F Purcell, N Newall, and M Farrer Change in ST segment elevation 60 minutes after thrombolytic initiation predicts clinical outcome as accurately as later electrocardiographic changes Heart, November 1, 1997; 78(5): 465 - 471. [Abstract] [Full Text] [PDF]

				E. M. Antman, H. W. Louwerenburg, H. F. Baars, J. C.L. Wesdorp, B. Hamer, J.-P. Bassand, F. Bigonzi, G. Pisapia, C. M. Gibson, H. Heidbuchel, et al. Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial Circulation, April 9, 2002; 105(14): 1642 - 1649. [Abstract] [Full Text] [PDF]